FTSE 100
Dow Jones
Nasdaq
CAC40
Dax

Friday, 18 September 2009

A simple question: there may be more

If the Barclays/Protium/C12 deal was all about a sale by Barclays to an unrelated purchaser so that Barclays earnings could be reported without mark-to-market fluctuations, why did Michael Keeley see fit to register a UK LLP at Linklaters offices in the name of C12 about a month ago?

C12 UK LLP
LINKLATERS LLP
1 SILK STREET
LONDON
EC2Y 8HQ

Company No. OC348082

No comments: